In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility
Ivey-Miranda J, Rao V, Cox Z, Moreno-Villagomez J, Mahoney D, Maulion C, Bellumkonda L, Turner J, Collins S, Wilson F, Krumholz H, Testani J. In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility. Circulation Heart Failure 2023, 16: e010206. PMID: 36896716, PMCID: PMC10186250, DOI: 10.1161/circheartfailure.122.010206.Peer-Reviewed Original ResearchConceptsAcute decompensated heart failureDecompensated heart failureDiuretic responseDiuretic dosingOral diureticsHeart failureMulticenter cohortHospital observationLower readmission ratesNet fluid balanceDays postdischargeReadmission ratesHospital readmissionUrine outputReadmission riskFluid statusFluid balanceHospital measuresDose selectionCohortProvider decisionsWeight changeReadmissionDiureticsPatientsCARDIAC REMODELING AFTER INTRAMYOCARDIAL AUTOLOGOUS BONE MARROW MONONUCLEAR CELL THERAPY FOR ISCHEMIC CARDIOMYOPATHY: 2-YEAR ECHOCARDIOGRAPHY RESULTS FROM THE CARDIAMP CELL THERAPY HEART FAILURE TRIAL OPEN-LABEL ROLL-IN COHORT
Johnston P, Bellumkonda L, Raval A, Anderson R, Holmes-Higgin D, Pepine C. CARDIAC REMODELING AFTER INTRAMYOCARDIAL AUTOLOGOUS BONE MARROW MONONUCLEAR CELL THERAPY FOR ISCHEMIC CARDIOMYOPATHY: 2-YEAR ECHOCARDIOGRAPHY RESULTS FROM THE CARDIAMP CELL THERAPY HEART FAILURE TRIAL OPEN-LABEL ROLL-IN COHORT. Journal Of The American College Of Cardiology 2023, 81: 740. DOI: 10.1016/s0735-1097(23)01184-1.Peer-Reviewed Original Research